Patient-Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019.
Publication
, Journal Article
Bhatnagar, V; Hudgens, S; Piault-Louis, E; Jones, L; Beaver, JA; Lyerly, HK; Reaman, G; Fleming, T; Kluetz, PG
Published in: Oncologist
October 2020
The measurement and analysis of patient‐reported outcomes is important in cancer clinical trials. This commentary reports advances and challenges from presentations at the 2019 Accelerating Anticancer Agent Development and Validation (AAADV) Workshop Patient‐Reported Outcomes Session.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Oncologist
DOI
EISSN
1549-490X
Publication Date
October 2020
Volume
25
Issue
10
Start / End Page
819 / 821
Location
England
Related Subject Headings
- Patient Reported Outcome Measures
- Oncology & Carcinogenesis
- Medical Oncology
- Humans
- Antineoplastic Agents
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Bhatnagar, V., Hudgens, S., Piault-Louis, E., Jones, L., Beaver, J. A., Lyerly, H. K., … Kluetz, P. G. (2020). Patient-Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019. Oncologist, 25(10), 819–821. https://doi.org/10.1634/theoncologist.2020-0062
Bhatnagar, Vishal, Stacie Hudgens, Elisabeth Piault-Louis, Lee Jones, Julia A. Beaver, H Kim Lyerly, Gregory Reaman, Thomas Fleming, and Paul G. Kluetz. “Patient-Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019.” Oncologist 25, no. 10 (October 2020): 819–21. https://doi.org/10.1634/theoncologist.2020-0062.
Bhatnagar V, Hudgens S, Piault-Louis E, Jones L, Beaver JA, Lyerly HK, et al. Patient-Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019. Oncologist. 2020 Oct;25(10):819–21.
Bhatnagar, Vishal, et al. “Patient-Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019.” Oncologist, vol. 25, no. 10, Oct. 2020, pp. 819–21. Pubmed, doi:10.1634/theoncologist.2020-0062.
Bhatnagar V, Hudgens S, Piault-Louis E, Jones L, Beaver JA, Lyerly HK, Reaman G, Fleming T, Kluetz PG. Patient-Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019. Oncologist. 2020 Oct;25(10):819–821.
Published In
Oncologist
DOI
EISSN
1549-490X
Publication Date
October 2020
Volume
25
Issue
10
Start / End Page
819 / 821
Location
England
Related Subject Headings
- Patient Reported Outcome Measures
- Oncology & Carcinogenesis
- Medical Oncology
- Humans
- Antineoplastic Agents
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis